Christopher R. Zito
University of Pisa(IT)
Publications by Year
Research Areas
Melanoma and MAPK Pathways, Cancer Immunotherapy and Biomarkers, CAR-T cell therapy research, Cutaneous Melanoma Detection and Management, Immunotherapy and Immune Responses
Most-Cited Works
- → Long-Term Survival of Patients With Melanoma With Active Brain Metastases Treated With Pembrolizumab on a Phase II Trial(2018)276 cited
- → Characterization of PD-L1 Expression and Associated T-cell Infiltrates in Metastatic Melanoma Samples from Variable Anatomic Sites(2015)201 cited
- → PD-L1 Studies Across Tumor Types, Its Differential Expression and Predictive Value in Patients Treated with Immune Checkpoint Inhibitors(2017)155 cited
- → PD-L1 Expression in Clear Cell Renal Cell Carcinoma: An Analysis of Nephrectomy and Sites of Metastases(2014)153 cited
- → Dimeric SecA is essential for protein translocation(2005)102 cited
- → PLEKHA5 as a Biomarker and Potential Mediator of Melanoma Brain Metastasis(2014)90 cited
- → Vertical Targeting of the Phosphatidylinositol-3 Kinase Pathway as a Strategy for Treating Melanoma(2010)77 cited
- → B cell depletion or absence does not impede anti-tumor activity of PD-1 inhibitors(2019)77 cited
- → Phosphatidylinositol-3-Kinase as a Therapeutic Target in Melanoma(2009)71 cited
- → Characterization of tumor infiltrating lymphocytes in paired primary and metastatic renal cell carcinoma specimens(2015)63 cited